Arzneimittelkommission der deutschen rzteschaftWissenschaftlicher Fachausschuss der Bundesrztekammer
It has a alexa rank of #1,237,710 in the world. It is a domain having .de extension. It is estimated worth of $ 960.00 and have a daily income of around $ 4.00. As no active threats were reported recently, akdae.de is SAFE to browse.
Daily Unique Visitors: | 708 |
Daily Pageviews: | 1,416 |
Income Per Day: | $ 4.00 |
Estimated Worth: | $ 960.00 |
Google Indexed Pages: | Not Applicable |
Yahoo Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Google Backlinks: | Not Applicable |
Bing Backlinks: | Not Applicable |
Alexa BackLinks: | Not Applicable |
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Very Poor |
WOT Privacy: | Very Poor |
WOT Child Safety: | Very Poor |
Alexa Rank: | 1,237,710 |
PageSpeed Score: | 68 ON 100 |
Domain Authority: | 49 ON 100 |
Bounce Rate: | Not Applicable |
Time On Site: | Not Applicable |
Total Traffic: | No Data |
Direct Traffic: | No Data |
Referral Traffic: | No Data |
Search Traffic: | No Data |
Social Traffic: | No Data |
Mail Traffic: | No Data |
Display Traffic: | No Data |
Als Ziel einer Behandlung der rheumatoiden Arthritis (RA) wird die Remission oder zumindest – insbesondere bei länger bestehender Erkrankung – eine geringe Krankheitsaktivität...
The Drug Commission of the German Medical Association (DCGMA) is the scientific expert committee for drug-related matters of the German Medical Association.
akdae.de Competitive Analysis, Marketing Mix and Traffic . vs. gelbe-liste.de arznei-telegramm.de der-arzneimittelbrief.de bfarm.de. Overview. Find, Reach, and Convert Your...
Alexander S. Kekulé (born November 7, 1958, as Alexander Urchs in Munich) is a German doctor and biochemist.Since 1999 he has held the chair for Medical Microbiology and...
SEO Bewertung von akdae.de. Onpage Analyse, Seitenstruktur, Seitenqualität, Links und konkurrierende Webseiten.
Vérifiez akdae.de site est une arnaque ou un site Web sécurisé. akdae.de détecter si elle est une arnaque, frauduleuse ou est infectés par des malwares, le …
Comprobar si akdae.de es un sitio web de estafa o un sitio web seguro. Detecte si akdae.de es una estafa, fraudulento o esta infectado con malware, phishing, fraude y si tiene...
Überprüfen Sie, ob akdae.de ein Betrug Website oder eine sichere Website ist. Ermitteln Sie, ob akdae.de ist ein Betrug, betrügerische oder infiziert mit Malware, Phishing,...
This article is an orphan, as no other articles link to it.Please introduce links to this page from ; try the Find link tool for suggestions. (August 2019)
The Drug Commission of the German Medical Profession (Arzneimittelkommission der deutschen Ärzteschaft, AkdÄ) is an expert committee of the Federal Medical Association...
[email protected]; PMID: 16149013 DOI: 10.1055/s-2005-916670 Abstract According to their code of professional conduct, German physicians are obliged to report suspected...
Affiliations 1 Drug Commission of the German Medical Association, Berlin, Germany. [email protected].; 2 NIHR School for Primary Care Research, Manchester Academic Health...
Akdae.de receives about 0 monthly visitors. This domain is ranked 0. Estimated worth of this site is $0.
SEO Bewertung von akdae.de. Onpage Analyse, Seitenstruktur, Seitenqualität, Links und konkurrierende Webseiten.
Abstract: Biosimilars have been available in Europe for more than 10 years, but their adoption in Germany has not been very successful. As their pharmaceutical quality, efficacy...
This page lists the current members of the European Medicines Agency's Management Board.. It lists each member's contact details, as well as his or her declaration of interests...
EMA receives applications for two COVID-19 vaccines. BioNTech/Pfizer and Moderna have submitted applications for their Covid-19 vaccines. The Agency’s human medicines committee...
Background Between 1988 and 1998, antibody-associated pure red-cell aplasia was reported in three patients who had undergone treatment with recombinant …
1. Dtsch Arztebl Int. 2010 Apr;107(16):279-85. doi: 10.3238/arztebl.2010.0279. Epub 2010 Apr 23. The financing of drug trials by pharmaceutical companies and its consequences.
Mar 27, 2017 · Multiple sclerosis (MS) is a chronic and progressive autoimmune disease of the central nervous system. MS patients suffer from diverse symptoms, whereas gait...
May 14, 2007 · A California company is marketing the latest in dietary supplements, an extract from algae they claim will boost the number of circulating stem cells, easing...
H1 Headings: | 1 | H2 Headings: | 1 |
H3 Headings: | 35 | H4 Headings: | 11 |
H5 Headings: | 12 | H6 Headings: | Not Applicable |
Total IFRAMEs: | Not Applicable | Total Images: | 44 |
Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
der AkdÄ | 20 | 1.476 % | No |
Drug Safety | 18 | 1.328 % | No |
Safety Mail | 18 | 1.328 % | No |
in der | 14 | 1.033 % | No |
SGB V | 9 | 0.664 % | No |
Nutzenbewertung § | 9 | 0.664 % | No |
RoteHandBrief zu | 9 | 0.664 % | No |
frühe Nutzenbewertung | 8 | 0.59 % | No |
§ 35a | 8 | 0.59 % | No |
35a SGB | 8 | 0.59 % | No |
AkdÄ zu | 7 | 0.517 % | No |
– frühe | 6 | 0.443 % | No |
Mehr Informationen | 6 | 0.443 % | No |
V Volltext | 6 | 0.443 % | No |
Neue Arzneimittel | 5 | 0.369 % | No |
Fortbildungsveranstaltung der | 5 | 0.369 % | No |
Oktober 2019 | 4 | 0.295 % | No |
Stellungnahme der | 4 | 0.295 % | No |
AkdÄ in | 4 | 0.295 % | No |
Terminhinweis Fortbildungsveranstaltung | 4 | 0.295 % | No |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
§ 35a SGB V | 8 | 0.59 % | No |
Nutzenbewertung § 35a SGB | 7 | 0.517 % | No |
35a SGB V Volltext | 6 | 0.443 % | No |
frühe Nutzenbewertung § 35a | 6 | 0.443 % | No |
– frühe Nutzenbewertung § | 6 | 0.443 % | No |
Arzneiverordnung in der Praxis | 4 | 0.295 % | No |
Stellungnahme der AkdÄ zu | 4 | 0.295 % | No |
Terminhinweis Fortbildungsveranstaltung der AkdÄ | 4 | 0.295 % | No |
Fortbildungsveranstaltung der AkdÄ in | 4 | 0.295 % | No |
in der Praxis AVP | 3 | 0.221 % | No |
Volltext 02102019 Drug Safety | 2 | 0.148 % | No |
02102019 Drug Safety Mail | 2 | 0.148 % | No |
des studentischen Netzwerks gegen | 2 | 0.148 % | No |
studentischen Netzwerks gegen Interessenkonflikte | 2 | 0.148 % | No |
von Fach und Gebrauchsinformationen | 2 | 0.148 % | No |
gegen Interessenkonflikte in der | 2 | 0.148 % | No |
16 Oktober 2019 Volltext | 2 | 0.148 % | No |
atopischen Dermatitis mit Dupilumab | 2 | 0.148 % | No |
Änderung von Fach und | 2 | 0.148 % | No |
Netzwerks gegen Interessenkonflikte in | 2 | 0.148 % | No |
Host | IP Address | Country | |
---|---|---|---|
nsa8.schlundtech.de | 62.116.159.18 | Germany | |
nsb8.schlundtech.de | 217.160.113.58 | Germany | |
nsc8.schlundtech.de | 89.146.248.28 | Germany | |
nsd8.schlundtech.de | 74.208.254.28 | Germany |
Host | Type | TTL | Extra |
---|---|---|---|
akdae.de | A | 86365 |
IP: 185.236.252.151 |
akdae.de | NS | 86400 |
Target: nsb8.schlundtech.de |
akdae.de | NS | 86400 |
Target: nsa8.schlundtech.de |
akdae.de | NS | 86400 |
Target: nsc8.schlundtech.de |
akdae.de | NS | 86400 |
Target: nsd8.schlundtech.de |
akdae.de | SOA | 86400 |
MNAME: nsa8.schlundtech.de RNAME: webmaster.akdae.de Serial: 2018060700 Refresh: 43200 Retry: 7200 Expire: 1209600 |
akdae.de | MX | 86400 |
Priority: 100 Target: mail.akdae.de |
akdae.de | MX | 86400 |
Priority: 10 Target: mail01.akdae.de |
ARTDOXA - Community for Contemporary Art, artists and audience
Business Academy, jednogodisnje školovanje iz oblasti menadžmenta, preduzetništva, marketinga, poslovne administracije i Cambridge International Diploma in Business.